| Literature DB >> 29698893 |
Hanif Ahmad1, Shujaat Ahmad2, Mumtaz Ali1, Abdul Latif1, Syed Adnan Ali Shah3, Humera Naz3, Najeeb Ur Rahman1, Farzana Shaheen4, Abdul Wadood5, Hidayat Ullah Khan6, Manzoor Ahmad7.
Abstract
Three new norditerpenoids alkaloids, 1β-hydroxy,14β-acetyl condelphine (1), jadwarine-A (2), jadwarine-B (3) along with two known alkaloids isotalatizidine hydrate (4) and dihydropentagynine (5) were isolated from medicinal plant Delphinium denudatum. The structures of natural products 1-5 were established on the basis of HR-EIMS, 1H and 13C NMR (1D & 2D) spectroscopic data as well as by comparison from literature data. The structures of compound 1 and 4 were also confirmed by single crystal X-ray diffraction studies. In-vitro AChE and BChE enzyme inhibitory activities of compounds 1-5 and molecular docking studies were performed to investigate the possible molecular inhibitory mechanism of the isolated natural products. Compound 2, 4 and 5 showed competitive inhibitory effects by inhibiting AChE and BChE, respectively, while 1 and 3 showed non-competitive inhibition. This work is the first report that provides a supporting evidence about the use of constituents of Delphinium denudatum in cerebral dementia and Alzheimer diseases.Entities:
Keywords: Delphinium denudatum; Enzyme inhibition activity; Norditerpenoid alkaloids; X-ray crystallography
Mesh:
Substances:
Year: 2018 PMID: 29698893 DOI: 10.1016/j.bioorg.2018.04.008
Source DB: PubMed Journal: Bioorg Chem ISSN: 0045-2068 Impact factor: 5.275